Larkspur Health Acquisition Corp. (ticker: LSPR)

Merged into ZyVersa Therapeutics, ticker now ZVSA

LSPR

Completed

ZyVersa Therapeutics

ZVSA

First	2022-02-11	$3,447.50
Merger	2022-12-16	$1,127.00	67%
Merger +6mo	2023-06-20	$101.85	97%
Merger +1yr	2023-12-18	$10.70	100%
Recent	2024-06-04	$4.71	100%

Larkspur Health Acquisition Corp.

Sponsors: Larkspur Health M2B Funding Corporation Apollo Management Group Alpha Capital Anstalt Range Ventures Francis Knuettel II Nicholas Kovacevich Thomas Poletti

Underwriter: A.G.P., Brookline Capital Markets, The Benchmark Company

Leadership: Daniel J. O’Connor, David S. Briones, Raj Mehra, Ph.D., J.D., Gregory Skalicky, Christopher Twitty, Ph.D., Raj Mehra, Ph.D., J.D.

Raised: $75M
CIK: 1859007
SPAC Ticker: LSPRU
Merger: ZyVersa Therapeutics
Merged Ticker: ZVSA
Focus: Biotech

Sign in for detailed analysis →

External link: SEC Filings